NCT07082556

Brief Summary

Ice hockey is a widely practiced sport, particularly in North America and Europe, with over 2,500 professional players in North America and approximately 2,000 in Europe. Its global expansion has extended participation to regions such as Africa and Australia. This sport demands high physical performance, speed, strategy, and specific preparation to prevent injuries. The most common injuries include muscular and joint trauma, especially in the knees, shoulders, and groin region, where "groin pain" is a frequent issue. Injuries to the hip joint, such as femoroacetabular impingement (FAI), acetabular labrum and cartilage lesions, and intra-articular loose bodies, are prevalent. Extra-articular injuries primarily involve the adductor and abdominal muscles. The biomechanics of ice skating require repetitive and forceful hip movements, increasing eccentric load on the adductors, particularly at higher skating speeds, thereby raising the risk of strains. Studies have shown that the adductor muscles, particularly the adductor longus, are the most frequently injured. Risk factors include a history of previous injury, high training intensity, strength imbalances between adductors and abductors, and inadequate preseason preparation. A critical threshold is the adductor/abductor strength ratio: if it falls below 80%, the risk of injury increases 17-fold. Invasive physiotherapy has gained prominence as an effective option for the treatment and prevention of such injuries. Ultrasound-guided invasive techniques, such as ultrasound-guided percutaneous neuromodulation (US-guided PNM), have demonstrated the ability to reduce muscle stiffness, improve intra- and intermuscular coordination, and enhance endurance. These techniques have shown greater efficacy than conventional methods, contributing to improved athletic performance and reduced injury risk. US-guided PNM is a minimally invasive technique that delivers electrical stimulation via needles placed under ultrasound guidance near peripheral nerves or motor points. The stimulation is adjusted according to therapeutic goals, whether to reduce pain, improve neuromuscular function, or modulate muscle tone. Its efficacy has been documented in studies showing improvements in flexibility, strength, and post-exertion recovery, with effects observed even in the contralateral limb, attributed to the crossover phenomenon. Given the high incidence of adductor injuries among hockey players and the associated risk factors, this clinical study aimed to evaluate the effectiveness of a single session of US-guided PNM in players with grade 0 (muscle contracture) injuries of the adductor muscles. Three primary variables were assessed: muscle strength (Adductor Squeeze Test), hip mobility (Bent Knee Fall Out Test), and subjective pain (VAS scale), both in daily activities and during on- and off-ice training.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 27, 2025

Completed
Same day until next milestone

Study Start

First participant enrolled

June 27, 2025

Completed
27 days until next milestone

First Posted

Study publicly available on registry

July 24, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2025

Completed
Last Updated

January 20, 2026

Status Verified

January 1, 2026

Enrollment Period

2 months

First QC Date

June 27, 2025

Last Update Submit

January 15, 2026

Conditions

Keywords

NeromodulationPercutaneousUltrasoundObturator nervehockey players

Outcome Measures

Primary Outcomes (3)

  • VAS (ADL)

    Pain during the activities of the daily life. This variable will be assessed through the Visual Analogue Scale (0-10 points)

    2 times, immediately pre-intervention and immediately after the first training posterior to the intervention.

  • VAS (ON ice)

    Pain during hockey training on ice. This variable will be assessed through the Visual Analogue Scale (0-10 points)

    2 times, immediately pre-intervention and immediately after the first training posterior to the intervention.

  • VAS (OFF ice)

    Pain during training out of the ice. This variable will be assessed through the Visual Analogue Scale (0-10 points)

    2 times, immediately pre-intervention and immediately after the first training posterior to the intervention.

Secondary Outcomes (2)

  • Maximum Isometric Strength. Hip Adductors

    2 times, immediately pre-intervention and immediately post-intervention

  • Passive hip mobility

    2 times, immediately pre-intervention and immediately post-intervention.

Study Arms (1)

US-guided PNM

EXPERIMENTAL

Each participant will be treated with US-guided PNM targeting the anterior branch of the obturator nerve.

Other: US-guided PNM

Interventions

Stimulation will be applied for 15 minutes at 4 Hz, using a 250 ms pulse duration.

US-guided PNM

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age over 18 years
  • Pain in the adductor region
  • Clinical diagnosis with ultrasound confirmation of the absence of structural damage, consistent with a grade 0 muscle injury (contracture) localized in the adductors

You may not qualify if:

  • Presence of muscle injuries above grade 0
  • Concomitant neurological, systemic, or orthopedic conditions
  • Recent application of neuromodulation techniques or other similar treatments performed by healthcare professionals within the last 7 days
  • Belonephobia (fear of needles)
  • Infections or skin disorders localized in the inguinal region

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Zaragoza

Zaragoza, 50006, Spain

Location

Study Officials

  • Pablo Herrero, Physiotherapist

    Universidad de Zaragoza

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 27, 2025

First Posted

July 24, 2025

Study Start

June 27, 2025

Primary Completion

September 1, 2025

Study Completion

October 1, 2025

Last Updated

January 20, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share

Data will be shared on a reasonable request contacting with the main author once data has been published. Anyway, Individual participant data (IPD) will be shared with other researchers in accordance with data sharing protocols and participant consent, ensuring confidentiality and ethical considerations are maintained.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Once research has been published
Access Criteria
Study protocol will be publish in a scientific journal

Locations